GB1441835A - Chloeritic medicines high voltage isolating switches - Google Patents

Chloeritic medicines high voltage isolating switches

Info

Publication number
GB1441835A
GB1441835A GB4894673A GB4894673A GB1441835A GB 1441835 A GB1441835 A GB 1441835A GB 4894673 A GB4894673 A GB 4894673A GB 4894673 A GB4894673 A GB 4894673A GB 1441835 A GB1441835 A GB 1441835A
Authority
GB
United Kingdom
Prior art keywords
propanol
medicine
chloeritic
high voltage
choleretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4894673A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Deutschland GmbH
Original Assignee
Klinge Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma GmbH and Co filed Critical Klinge Pharma GmbH and Co
Publication of GB1441835A publication Critical patent/GB1441835A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB4894673A 1972-10-26 1973-10-19 Chloeritic medicines high voltage isolating switches Expired GB1441835A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2252637A DE2252637C3 (de) 1972-10-26 1972-10-26 Verwendung von 1,3-Glycerindiäthern

Publications (1)

Publication Number Publication Date
GB1441835A true GB1441835A (en) 1976-07-07

Family

ID=5860169

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4894673A Expired GB1441835A (en) 1972-10-26 1973-10-19 Chloeritic medicines high voltage isolating switches

Country Status (6)

Country Link
US (1) US3888994A (en, 2012)
BE (1) BE806109A (en, 2012)
DE (1) DE2252637C3 (en, 2012)
FR (1) FR2204413B1 (en, 2012)
GB (1) GB1441835A (en, 2012)
NL (1) NL7314768A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978805A (en) * 1988-06-11 1990-12-18 Basf Aktiengesellschaft Polyethers

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215116A (en) * 1978-06-30 1980-07-29 Block Drug Company Inc. Propoxylate toxicants
FI803846A7 (fi) 1980-02-07 1981-08-08 F Hoffmann La Roche & Co Farmaseuttiset valmisteet.
DE3236496C2 (de) * 1982-09-30 1987-03-19 Buckau-Walther AG, 4048 Grevenbroich Verfahren zur extraktiven Abtrennung polarer organischer Verbindungen aus deren wäßrigen Lösungen
US4755167A (en) * 1984-04-10 1988-07-05 Research Corporation In vivo method for distribution and stirring of therapeutic agents
US4723941A (en) * 1985-09-06 1988-02-09 Research Corporation Pump for oscillating a fluid in vivo
US5798386A (en) * 1994-08-03 1998-08-25 Cell Therapeutics, Inc. Angiogenic lipid formulations
US5955624A (en) * 1994-08-03 1999-09-21 Cell Therapeutics, Inc. Growth stimulating factors
JP6277241B2 (ja) * 2016-09-09 2018-02-07 株式会社日本触媒 エーテル結合含有化合物を含む組成物およびその製造方法
US20210198179A1 (en) * 2019-12-30 2021-07-01 Industrial Technology Research Institute Compound and coating composition employing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6996M (en, 2012) * 1966-07-19 1969-06-02

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978805A (en) * 1988-06-11 1990-12-18 Basf Aktiengesellschaft Polyethers

Also Published As

Publication number Publication date
FR2204413A1 (en, 2012) 1974-05-24
US3888994A (en) 1975-06-10
DE2252637A1 (de) 1974-05-16
DE2252637C3 (de) 1979-07-19
FR2204413B1 (en, 2012) 1977-09-09
NL7314768A (en, 2012) 1974-05-01
DE2252637B2 (de) 1978-11-09
BE806109A (fr) 1974-02-01

Similar Documents

Publication Publication Date Title
CA1029303A (en) Method of contraception by the administration of stage-combination preparations
ES2044099T3 (es) Composiciones antiacidas que tienen un tiempo de permanencia gastrica prolongado.
NZ194047A (en) Medicinal preparations for the parenteral administration of fat-soluable medicaments
ATE56358T1 (de) Chlorfluorkohlenstoff-treibstoffaerosolpr|parate, die arzneimittel enthalten.
NL7714329A (nl) Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB1441835A (en) Chloeritic medicines high voltage isolating switches
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
NL7414186A (nl) Werkwijze ter bereiding van 1-ftalazonderivaten alsmede van farmaceutische preparaten die deze derivaten als actieve componenten omvatten.
CA967484A (en) Pharmaceutical compositions containing a vitamin a derivative
NL184682C (nl) Werkwijze voor de bereiding van piperazine-derivaten met anti-histamine-werking en werkwijze voor de bereiding van farmaceutische preparaten die ze bevatten.
IE39193B1 (en) Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
NL7614538A (nl) Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7608496A (nl) Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
IL49758A (en) 10-( -benzoylpiperidin-1-yl)alkyl)-phenothiazine derivatives,their preparation and pharmaceutical compositions containing them
CA1027447A (en) Device for the administration of powders
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
CA1029302A (en) Method of contraception by the administration of stage-combination preparations
NL184619C (nl) Werkwijze ter bereiding van anti-bacterieel werkzame farmaceutische preparaten alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte 5-benzyl-2,4-diaminopyrimidinederivaten.
NL7714205A (nl) Werkwijze ter bereiding van 5-fluoruracilderi- vaten en farmaceutische preparaten die deze derivaten bevatten.
GB1518559A (en) Naphthyl derivatives processes for their preparation an pharmaceutical compositions containing them
CA1023293A (en) Process for the preparation of medicinal oils
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
USD182507S (en) Merchandise display stand
DK218777A (da) Fremgangsmade til fremstilling af en farmaceutisk tabletkomposition indeholdende anti-allergisk legemiddel

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee